Table 2.
Variable | aPL positivity n (%) |
---|---|
Overall aPL positivity | 197 (20.6%) |
Anticardiolipin antibodies (aCL) | 165 (17.3%) |
IgG | 43 (4.5%) |
IgM | 126 (13.2%) |
Antibodies to β2-glycoprotein I (anti-β2GPI) | 87 (9.1%) |
IgG | 26 (2.7%) |
IgM | 65 (6.8%) |
Antiphosphatidyl-serine antibodies (aPS) | 58 (6.1%) |
IgG | 12 (1.3%) |
IgM | 46 (4.8%) |